Is Stent Placement Effective for Palliation of Right Ventricle to Pulmonary Artery Conduit Stenosis?  by Aggarwal, Sanjeev et al.
S
a
o
c
t
c
(
i
m
c
t
q
t
d
s
F
C
M
2
Journal of the American College of Cardiology Vol. 49, No. 4, 2007
© 2007 by the American College of Cardiology Foundation ISSN 0735-1097/07/$32.00
PCongenital Heart Disease
Is Stent Placement Effective for Palliation of
Right Ventricle to Pulmonary Artery Conduit Stenosis?
Sanjeev Aggarwal, MD, Swati Garekar, MD, Thomas J. Forbes, MD, FACC,
Daniel R. Turner, MD, FACC
Detroit, Michigan
Objectives This study was designed to evaluate the outcome of stent placement (SP) for conduit discrete stenosis using
predefined criteria.
Background Right ventricle (RV) to pulmonary artery (PA) conduits are often associated with complications, such as stenosis,
requiring multiple surgical replacements.
Methods Patients who underwent primary or repeat SP were included. Indications for SP were clinical symptoms and/or
RV to systolic blood pressure (SBP) ratio (RV:SBP) 0.65 by echocardiography. Our definition of success was a
decrease in RV:SBP by 20%, a final RV:SBP ratio of 0.65, or resolution of symptoms.
Results Stents were placed successfully in 28 of 31 patients (90%), including 3 patients who underwent the procedure
solely for symptoms. The RV:SBP ratio decreased (0.75  0.17 vs. 0.52  0.12, p  0.001), and the conduit
diameter increased (postero-anterior 9.1  2.9 vs. 12.0  2.8 mm, lateral 8.3  2.2 vs. 11.6  2.4 mm, p 
0.001). In the 28 patients with successful SP, 8 (29%) remained free from second intervention. In the remaining
patients, the median time to re-intervention was 16 months (range 6 to 44 months). Second transcatheter inter-
ventions (4 SP, 4 balloon dilation) were successful in 8 of 13 patients. Complications included balloon rupture
(n  4), stent fracture (n  2), and pseudoaneurysm formation (n  1).
Conclusions Initial SP has excellent intermediate outcomes, successfully postponing surgical intervention for the majority of
patients. Conduit restenosis may be successfully treated with a second transcatheter intervention. On the basis
of these data, SP is likely the procedure of choice for patients with a discrete stenosis of the RV to PA
conduit. (J Am Coll Cardiol 2007;49:480–4) © 2007 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.09.037p
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aurgical placement of a right ventricle (RV) to pulmonary
rtery (PA) conduit is the procedure of choice for palliation
f RV outflow tract obstruction in many forms of complex
ongenital heart disease. Conduit placement is limited by
he need for surgical replacement owing to progressive
onduit obstruction, valve dysfunction, or patient growth
1,2). Conduit replacement is associated with high morbid-
ty in patients with multiple previous cardiac procedures (3).
The most common reason for surgical conduit replace-
ent is stenosis (4). Because of surgical morbidity, trans-
atheter balloon angioplasty was initially used in an attempt
o relieve conduit stenosis with poor results (5–7). Subse-
uently, endovascular stent placement has emerged as a
herapeutic option to prolong the survival of RV-PA con-
uits, with improved results (3,8–10). Although these
tudies reported hemodynamic improvement after stent
rom the Division of Pediatric Cardiology, Children’s Hospital of Michigan, The
arman and Ann Adams Department of Pediatrics, Wayne State University, Detroit,
ichigan.s
Manuscript received June 24, 2005; revised manuscript received September 13,
006, accepted September 19, 2006.lacement, a strict definition of success was not used to
etermine immediate and intermediate outcomes. The
resent study examines: 1) our experience with stent place-
ent as treatment of RV-PA conduit discrete stenosis using
trict, predefined criteria for procedural success, and 2) our
ntermediate results of transcatheter intervention for the
ostponement of surgical conduit replacement.
ethods
pproval from the Human Investigation Committee of
ayne State University was secured for access to patients’
harts for this retrospective review. The catheterization
aboratory database from January 1993 to December 2003
as reviewed for patients who underwent stent placement in
V-PA conduits. Patients in whom additional pulmonary
rtery interventions were performed were excluded from the
tudy. The technique for stent implantation has been
reviously described (11,12). The indications for stent
lacement were clinical symptoms (e.g., exercise intoler-
nce, fatigue, or increasing cyanosis) and/or an RV to
ystolic blood pressure (SBP) ratio (RV:SBP) of 0.65 by
e
p
c
s
c
a
R
s
R
t
2
n
e
r
i
n
s
r
d
s
n
m
c
c
l
t
s
b
t
c
p
E
m
y
f
c
f
r
f
s
d
S
u
I
g
a
S
a
K
r
m
a
a
r
l
m
a
b
A
d
A
s
R
P
1
t
s
s
p
u
m
t
t
s
T
s
F
t
w
a
c
n
R
a
c
n
w
p
a
o
I
p
S
N
M
C
N
a
L
S
b
c
t
s
S
481JACC Vol. 49, No. 4, 2007 Aggarwal et al.
January 30, 2007:480–4 Stent Placement in RV to PA Conduit Stenosischocardiography. During the period of the study, every
atient who met these criteria and had a discrete stenosis on
atheterization underwent stent placement. However, if the
tenosis was diffuse or the patient had simply outgrown the
onduit, there was no attempt to place the stent.
The criteria used for defining procedural success were: 1)
decrease in the RV:SBP ratio by 20%, and 2) a final
V:SBP of0.65, or 3) a resolution of symptoms following
tent placement. These criteria were selected because a
V:SBP ratio of more than 0.65 is a widely accepted
hreshold for intervention, and a drop in RV:SBP by at least
0% limited the chance that small variations in hemody-
amics were interpreted as significant changes.
Patient records from clinic visits, surgical procedures,
chocardiograms, and cardiac catheterization were reviewed
etrospectively. For each patient, demographic data includ-
ng age, weight, gender, diagnosis, size and type of conduit,
umber of previous surgical replacements, and date of last
urgery were recorded. Catheterization data included di-
ectly measured RV:SBP and the peak systolic pressure
ifference across the conduit before and immediately after
tent placement. Angiographically, the site of conduit ste-
osis was defined as proximal (below the conduit valve),
id-portion (at or near the conduit valve), or distal (at the
onduit-pulmonary artery anastomosis). The narrowest
onduit diameter was measured on the postero-anterior and
ateral projections before and after transcatheter interven-
ion using the Siemens Cathcor system with online mea-
urement capability (Siemens Medical Solutions, Nurem-
erg, Germany). If the site of obstruction did not involve
he valve, only the stenotic proximal or distal segment of the
onduit was covered. The valve leaflets were preserved when
ossible.
A rigid protocol for follow-up was observed in our center.
chocardiograms were obtained on the day of stent place-
ent, between 3 and 6 months after the procedure, and
early thereafter. Additional echocardiograms were per-
ormed in case of symptoms. Echocardiographic data in-
luded before and after stent placement and most recent
ollow-up RV systolic pressure estimate from tricuspid
egurgitation, RV:SBP, and the peak systolic pressure dif-
erence across the conduit. Study end points included
urgical conduit replacement or the most recent follow-up
ata.
tatistical analysis. Statistical analyses were performed
sing SPSS software, version 11.5 (SPSS Inc., Chicago,
llinois). Patient demographic, hemodynamic, and angio-
raphic data are described as frequency, median (range),
nd mean  SD as appropriate. The paired, 2-tailed
tudent t test was used for analyzing hemodynamic and
ngiographic data before and after stent placement.
aplan-Meier curves were used to plot freedom from
e-intervention. The Cox proportional hazard regression
odel was used to compare multivariate relationships
mong patient characteristics, conduit and stent types,
nd other procedural characteristics with freedom from (e-intervention. Univariate re-
ationships among patient de-
ographics, hemodynamics,
nd outcomes were evaluated
y linear regression, 1-way
NOVA, and 2-sample Stu-
ent t tests when appropriate.
p value of 0.05 was used for
tatistical significance.
esults
atient characteristics. A total of 31 patients (14 men and
7 women) underwent 38 stent placement procedures for
reatment of RV-PA conduit stenosis. In 6 of 31 patients, a
econd (n  5) or third (n  1) stent was placed during
eparate catheterization procedures. During the same time
eriod, 28 patients did not qualify for stent placement and
nderwent surgical replacement of the RV-PA conduit. The
edian age at initial stent placement was 12 years (range 1.5
o 25.6 years), and the median weight was 39 kg (range 7.9
o 89.4 kg). In our cohort, 7 of 31 patients (25%) were
ymptomatic, and 4 of them had RV:SBP ratios 0.65.
hree patients underwent stent placement solely because of
ymptoms. The primary diagnoses included tetrology of
allot with (n  4) or without (n  10) pulmonary atresia,
runcus arteriosus (n  8), transposition of great arteries
ith pulmonary stenosis (n  8), and aortic stenosis status
fter the Ross procedure (n  1). The number of surgical
onduit revisions performed before stent placement were
one (n  16), 3 (n  9), 2 (n  5), and 1 (n  1). The
V-PA conduits were cryopreserved pulmonary (n 14) or
ortic (n  8) homografts or Dacron tubes (n  8); 1
onduit type was unknown. There were 25 valved and 6
onvalved conduits. The median original conduit diameter
as 17 mm (range 7 to 27 mm). Mild to moderate
ulmonary insufficiency was recorded on echocardiogram in
ll except 2 patients who had severe stenosis with a gradient
f 80 to 90 mm Hg across the conduit.
nitial stent placement. The site of conduit obstruction was
roximal (n  7), mid-portion (n  17), or distal (n  7).
tent type was Palmaz (n  21; Cordis Corp., Warren,
ew Jersey), Large Diameter (n  4; eV3, Minneapolis,
innesota), Genesis-XD (n  4; Cordis Corp.), and
heatham-Platinum (n  2; NuMED, Inc., Hopkinton,
ew York). The choice of stent was based on availability
nd size. Palmaz stents were used for size 18 mm and
arge Diameter or Cheatham-Platinum for size 8 mm.
ince the Genesis XD stent became available in 2000, it has
een preferred for conduits 18 mm. The RV pressure,
onduit gradient, RV:SBP ratio, and conduit diameter at
he site of stenosis improved significantly immediately after
tent placement (Table 1).
Echocardiographic estimates of RV pressure and RV:
BP ratio were similarly improved after stent placement
Abbreviations
and Acronyms
PA  pulmonary artery
RV  right ventricle/
ventricular
SBP  systolic blood
pressure
SP  stent placementTable 2).
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Stent Placement in RV to PA Conduit Stenosis January 30, 2007:480–4Our definition of success was met in 28 of 31 (90%) initial
tent procedures, including the 3 whose symptoms resolved
ollowing the procedure. In 1 unsuccessful procedure, RV:
BP decreased by 44% but did not fall below 0.65 (1.26
efore vs. 0.71 after stent). No significant change in RV:SBP
as found in the 2 remaining procedures. Univariate analysis
howed that a higher before-stent, directly measured RV
ystolic pressure (91.7  42.1 mm Hg vs. 68.5 
5.3 mm Hg) and a higher estimated echocardiographic
onduit gradient (75  30.8 mm Hg vs. 63.4  11.2 mm
g) were significantly associated with failure. Success was
ot significantly associated with patient age at the time of
onduit or stent placement, weight, gender, diagnosis,
onduit size, type of stent, or location of stenosis.
ollow-up. Of the 28 patients with successful procedures,
(29%) continued to have a RV:SBP of0.65 (0.53 0.7)
y echocardiography at latest follow-up (median 36 months,
ange 10 to 74 months). The RV systolic pressure estimate
as 61.3 12.4 mmHg. Of the remaining 20 patients with
nitial success, 13 underwent transcatheter re-intervention,
underwent surgical conduit replacement, and 2 were lost
o follow-up. The median time to re-intervention was 16
onths (range 6 to 44 months). The freedom from re-
ntervention, based on Kaplan-Meier analysis, was noted in
7% of patients at 1 year, 50% at 2 years, and 33% at 3 years
Fig. 1). The criteria for re-intervention were the same as for
nitial intervention.
Of the 3 patients with unsuccessful initial procedures, 1
ad a dramatic decrease in RV:SBP from 1.26 to 0.71 but
id not meet our criteria for success. At a repeat catheter-
zation 12 months after the initial procedure, a stent fracture
as noted. A second stent was placed over the fractured
tent, but the procedure did not improve the RV:SBP ratio,
nd the patient underwent surgical conduit replacement.
atheterization Data Beforend After Initial Stent Plac ment
Table 1 Catheterization Data Beforeand After Initial Stent Placement
Parameters
Before Stent
(Mean  SD)
After Stent
(Mean  SD)
p Value
(n  31)
Right ventricular pressure
(mm Hg)
70.7 19.4 54.7 13.2 0.001
RV:SBP ratio 0.75 0.17 0.52 0.12 0.001
Conduit diameter,
postero-anterior view (mm)
9.1 2.9 12 2.8 0.001
Conduit diameter,
lateral view (mm)
8.3 2.2 11.6 2.4 0.001
V:SBP  right ventricular to systolic blood pressure ratio.
chocardiographic Data Beforend After Initial Stent Placem nt
Table 2 Echocardiographic Data Beforeand After Initial Stent Placement
Parameters
Pre-Cath
(Mean  SD)
Post-Cath
(Mean  SD)
p Value
(n  38)
Right ventricular pressure
(mm Hg)
83 13.3 56 12.5 0.001
RV:SBP ratio 0.79 0.12 0.52 0.11 0.01bbbreviations as in Table 1.alloon dilation of a previously placed stent was performed
n another patient. In a third patient with tetralogy of Fallot,
ulmonary atresia, and a residual ventricular septal defect,
eripheral arterial saturation increased after stent place-
ent, although the procedure did not meet our definition of
uccess.
epeat transcatheter intervention after initial success.
epeat stent placement was performed in 5 patients. The
ndications were stenosis at a different site within the
onduit (n  4) and stent fracture (n  1). Palmaz stents
ere used in all 5 patients. Of the 3 patients who met our
riteria for success after the second stent procedure, all were
e-intervention free at follow-up (median 42 months, range
7 to 56 months). Of the 2 failures, one patient could not
ndergo stent placement because of non-availability of an
ppropriately sized balloon. He subsequently underwent a
uccessful stent placement procedure. The other failure
nderwent surgical replacement of the conduit.
Transcatheter balloon dilation of the previously placed
tent was performed in 8 patients. Before the year 2000, the
pti-Pro balloon (Cordis Corp.) was used for stent sizes
12 mm and the Blue-Max balloon for sizes 15 mm.
iven the propensity of these balloons to rupture, since
000, we have used the Cordis Powerflex for stent sizes12
m, Cordis Max for stents 12 to 15 mm, and the Bib
alloon for stents 15 mm. It is important to use high-
ressure balloons with the largest possible diameter. Of the
patients who met our criteria for success after balloon
ngioplasty, 2 are re-intervention–free, and 2 required
urgical conduit replacement at follow-up (median 49
onths, range 15 to 55 months).
Overall, repeat transcatheter intervention was successful
n 7 of 13 (53.8%) patients. Surgery was ultimately delayed
Figure 1 Freedom From Re-Intervention After Initial
Stent Placement in 28 Successful Procedures
RV:SBP  right ventricular to systolic blood pressure ratio.y a median of 42 months (range 15 to 56 months).
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January 30, 2007:480–4 Stent Placement in RV to PA Conduit Stenosisurgery. By the end of the study period, 17 patients had
ndergone surgical conduit replacement. No technical dif-
culties were encountered secondary to the previously
laced stents. The methodology employed was to cut open
he conduits from end to end with the stents in situ.
omplications. Complications were encountered in 9 of
8 procedures (24%), including balloon rupture (n  4),
tent fracture (n  2), stent malposition after balloon
upture requiring deployment of the stent in the inferior
ena cava (n  1), partial occlusion of the proximal left
ulmonary artery (n  1), and pseudoaneurysm formation
n  1). The pseudoaneurysm and stent fractures were
oted at subsequent cardiac catheterizations. A certain
egree of calcification was present in all cases; when severe,
alloon dilation was performed at the site of stenosis before
tent placement. All complications were encountered in the
rst 5 years of our experience, and none required emergent
urgical intervention. There were no deaths.
iscussion
or the past 3 decades, surgical placement of conduits from
he right (sub-pulmonary) ventricle to the pulmonary arter-
es has been used for palliation of RV outflow tract obstruc-
ion associated with complex congenital heart defects (13–
5). Although advances in surgical technique and
vailability of newer types of conduits have improved
utcome, more than 50% of conduits require replacement
ithin 10 years.
Conduit stenosis is the most common reason for re-
ntervention (4,14). Surgical conduit replacement is associ-
ted with high morbidity owing to multiple ventriculoto-
ies and cardioplegia/cardiopulmonary bypass (3). Repeat
idline sternotomies are frequently technically difficult
ecause of fibrosis and adherence of the conduit to the
ternum. Furthermore, subsequent (replaced) homograft
onduits have a shorter lifespan (14). Therefore, nonsurgi-
al, less invasive methods to prolong conduit lifespan are
mportant to the clinical care of patients with congenital
eart disease.
Transcatheter balloon angioplasty of conduit stenosis is
ssociated with limited success owing to rapid recoil of the
onduit wall (5,7). More recently, stent placement for
onduit stenosis was first performed on baboons and sub-
equently on humans with a significant decrease in the
V:SBP ratio after stent placement (3,8–10,12,16). Unfor-
unately, none of these previous studies used a strict defini-
ion of success, so that institutional bias may be present in
eporting. Furthermore, there are limited follow-up data on
hether conduit stent placement results in a meaningful
elay of surgical replacement in patients with conduit
tenosis.
Using our strict criteria for success, conduit lifespan was
rolonged for 1 year in 67% of patients and for at least 36
onths in 33% of patients after stent placement. Each of
hese patients would otherwise have been a candidate for iurgical intervention. Furthermore, repeat conduit interven-
ion for conduit restenosis was successful in 54% of patients
ithout significant complications. Therefore, with 2 trans-
atheter interventions, conduit lifespan was extended for a
edian of 42 months in this study. Complications in our
tudy were infrequent and occurred in the first few years.
his could be attributed to multiple reasons, including a
earning curve and improvement in skills in the operator;
vailability of high-pressure, more compliant balloons; im-
roved stent design; and availability of bigger stents. The
ffect of stent placement on later surgical procedures,
pecifically the bypass times in comparison to children with
onduits without stents, needs to be evaluated in future
rospective studies.
Worsening of pulmonary insufficiency with stent place-
ent across a valved conduit is reported in published data
nd may be aggravated by distal obstruction in pulmonary
rteries. The extent and evolution of the deleterious effect of
alvular regurgitation on RV function is not clearly known.
owever, there is a serious concern that progressive pulmo-
ary valve regurgitation may increase susceptibility to ar-
hythmias and cause sudden death and RV dysfunction,
hich may be irreversible in some cases (17,18). Even in the
resence of pulmonary valve regurgitation, stent placement
ould be a useful short-term solution to prolong the life of
he stenosed conduit and avoid multiple surgical replace-
ents and cardiopulmonary bypass. This may enable place-
ent of bigger conduits after a period of somatic growth.
esides, if stenosis coexists with insufficiency, stent place-
ent may alleviate the pressure overload on the RV.
Recently, there has been increasing experience with and
nterest in the percutaneous placement of bovine valves
ithin a balloon expandable stent. The advantage of this
echnique is that it relieves conduit obstruction without
ausing pulmonary valve insufficiency. The data are cur-
ently limited to patients who weigh more than 20 kg,
ong-term outcomes are scarce, and the technique is not
vailable in the U.S. (19,20). A single case report in a
0-month-old demonstrates the technical feasibility of the
rocedure in smaller patients (21). In the future, with
mprovement in technology, this procedure is likely to
ecome a nonsurgical therapeutic option.
The issue of possible compression of the proximal coro-
ary artery during stent placement is a concern in patients
ith tetralogy of Fallot who have undergone conduit place-
ent because of an anomalous coronary artery (22). In our
eries, 2 patients with tetralogy of Fallot had conduit stent
lacement without any coronary artery complications. It is
mperative that this patient population has a coronary artery
valuation before and after stent placement. If necessary, an
ngioplasty balloon may be inflated during simultaneous
oronary angiography.
tudy limitations. This is a retrospective analysis of data.
omplications may be underestimated, as there was no
outine surveillance of patients other than by clinical find-
ngs and echocardiograms. Information on RV dimensions
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Stent Placement in RV to PA Conduit Stenosis January 30, 2007:480–4nd sensitive functional analysis, such as exercise testing,
ver the duration of follow-up was not available from our
etrospective analysis.
onclusions. Stent placement as the initial treatment for
onduit stenosis is safe, effective, and has excellent interme-
iate outcomes. Surgical conduit replacement is delayed
fter stent placement in the majority of patients. Conduit
estenosis may be successfully treated with a second trans-
atheter intervention, including balloon angioplasty of the
reviously placed stent and/or placement of an additional
tent. On the basis of these data, stent placement appears to
e the procedure of choice for patients with a discrete
tenosis of the RV to pulmonary artery conduit.
eprint requests and correspondence: Dr. Sanjeev Aggarwal,
ivision of Pediatric Cardiology, Children’s Hospital of Michi-
an, 3901 Beaubien Boulevard, Detroit, Michigan 48201. E-mail:
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